Literature DB >> 8992977

T cell-derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naive human CD4 T cells.

Y Ohshima1, G Delespesse.   

Abstract

Previous studies on human Th subset development were restricted to the analysis of naive T cells activated with anti-CD3 mAb in the absence of physiologic APC. In this study, we have analyzed the role of cytokines and physiologic APC on T cell maturation in an Ag-specific system, in which naive neonatal CD4 T cells were primed with allogeneic dendritic cells (DC). We found that the cytokine profile of primed cells was dependent upon 1) the ratio between T cells and allogeneic DC and 2) the endogenous production of IL-4 and IL-12. Neutralization of IL-4 during primary MLR increased IFN-gamma production at priming and shifted the phenotype of primed cells from Th0 to Th1. These effects were IL-12 dependent, in that they were suppressed by anti-IL-12 Abs. The production of IL-12 in primary MLR was further evidenced by the presence of IL-12 p40 in the culture supernatant fluids. IL-12 production was suppressed by exogenous IL-4 and increased by anti-IL-4 blocking mAbs, indicating that endogenous IL-4 down-regulated IL-12 production by DC. Finally, IL-12 was produced as a result of T cell/DC interaction involving the CD40/CD40 ligand and CD28/B7 costimulation pathways, as revealed by the inhibitory effect of anti-CD40 ligand mAb and CTLA-4Ig. These observations suggest that in neutral conditions, Ag presentation by DC results in the coordinate production of naive T cell-derived IL-4 and DC-derived IL-12 that in concert shape the cytokine profile of Th cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8992977

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Rachel Elizabeth Martin; Tomoki Ito; Farrah Kheradmand; David Brian Corry; Yong-Jun Liu; Matthew Moyle
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 2.  DNA vaccines: safety and efficacy issues.

Authors:  D M Klinman; M Takeno; M Ichino; M Gu; G Yamshchikov; G Mor; J Conover
Journal:  Springer Semin Immunopathol       Date:  1997

Review 3.  Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer.

Authors:  M T Lotze
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

Review 4.  T cell-mediated immune responses in human newborns: ready to learn?

Authors:  A Marchant; M Goldman
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  Human T lymphocyte priming in vitro by haptenated autologous dendritic cells.

Authors:  T Rustemeyer; S De Ligter; B M Von Blomberg; P J Frosch; R J Scheper
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus.

Authors:  M S P Azevedo; L Yuan; S Pouly; A M Gonzales; K I Jeong; T V Nguyen; L J Saif
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model.

Authors:  Ana M González; Marli S P Azevedo; Kwonil Jung; Anastasia Vlasova; Wei Zhang; Linda J Saif
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

Review 8.  Infection of dendritic cells by lymphocytic choriomeningitis virus.

Authors:  N Sevilla; S Kunz; D McGavern; M B A Oldstone
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

9.  Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.

Authors:  C Nataraj; D W Thomas; S L Tilley; M T Nguyen; R Mannon; B H Koller; T M Coffman
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Differential effects of tumour necrosis factor-alpha and interleukin-12 on isopentenyl pyrophosphate-stimulated interferon-gamma production by cord blood Vgamma9 T cells.

Authors:  Eduardo Jose Campos Alberto; Naoki Shimojo; Masahiko Aoyagi; Yoichi Kohno
Journal:  Immunology       Date:  2008-11-14       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.